Read more

Read more

Read more

Read more
DNA Genetics’ Charles Phillips Talks Cannabis Branding with CFN Media
Ash Stringer August 5th, 2019 App, Exclusive, News, Top Story As the cannabis market moves from the back alley to the boardroom, we are gaining an increasing appreciation for the role genetics play in developing distinct varieties with unique medical and commercial application. As the cannabis market matures, the... Read more
XPhyto Therapeutics Ready to Be Cannabis’ Newest Public Entity
Ryan Allway August 2nd, 2019 Exclusive, News, Top Story, Uncategorized Only days after announcing that its wholly owned subsidiary was awarded a German cannabis and cultivation and extraction licence, XPhyto Therapeutics is ready to enter the public domain. With a final prospectus filed with the British Columbia Securities Commission,... Read more

Read more

Cannabis Stocks: Not Just Cheap, Stupid-Cheap

In the fall of 2017, the entire Canadian cannabis industry more than quadrupled in value. Today, cannabis industry fundamentals are much stronger, while stock valuations are relatively lower.

Read more

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )